These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. Ismail M; Ahmed S; Kastner C; Davies J BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081 [TBL] [Abstract][Full Text] [Related]
64. Focal prostate cryoablation: initial results show cancer control and potency preservation. Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628 [TBL] [Abstract][Full Text] [Related]
65. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. Zagars GK J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725 [TBL] [Abstract][Full Text] [Related]
66. Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience. Yuh B; Ruel N; Muldrew S; Mejia R; Novara G; Kawachi M; Wilson T BJU Int; 2014 May; 113(5):769-76. PubMed ID: 24314031 [TBL] [Abstract][Full Text] [Related]
67. Endoscopic extraperitoneal radical prostatectomy after previous transurethral resection of prostate: oncologic and functional outcomes of 100 cases. Do M; Haefner T; Liatsikos E; Kallidonis P; Hicks J; Dietel A; Horn LC; Rabenalt R; Stolzenburg JU Urology; 2010 Jun; 75(6):1348-52. PubMed ID: 19914701 [TBL] [Abstract][Full Text] [Related]
68. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Onik G Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431 [TBL] [Abstract][Full Text] [Related]
69. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years. Thüroff S; Chaussy C J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962 [TBL] [Abstract][Full Text] [Related]
70. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Onik G; Narayan P; Vaughan D; Dineen M; Brunelle R Urology; 2002 Jul; 60(1):109-14. PubMed ID: 12100934 [TBL] [Abstract][Full Text] [Related]
71. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml. Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384 [TBL] [Abstract][Full Text] [Related]
72. Recurrence after radical prostatectomy for organ-confined prostate cancer. Scheepe JR; Vis AN; Mickisch GH Onkologie; 2003 Aug; 26(4):330-3. PubMed ID: 12972697 [TBL] [Abstract][Full Text] [Related]
73. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation. Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436 [TBL] [Abstract][Full Text] [Related]
74. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Ellis DS Urology; 2002 Aug; 60(2 Suppl 1):34-9. PubMed ID: 12206846 [TBL] [Abstract][Full Text] [Related]
75. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach. Salomon L; Levrel O; Anastasiadis AG; Saint F; de La Taille A; Cicco A; Vordos D; Hoznek A; Chopin D; Abbou CC Prostate Cancer Prostatic Dis; 2002; 5(4):285-90. PubMed ID: 12627213 [TBL] [Abstract][Full Text] [Related]
76. Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: a multicentre audit. Winkler MH; Khan FA; Hoh IM; Okeke AA; Sugiono M; McInerney P; Boustead GB; Persad R; Kaisary AV; Gillatt DA BJU Int; 2004 Apr; 93(6):725-9. PubMed ID: 15049980 [TBL] [Abstract][Full Text] [Related]
77. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. Guillonneau B; el-Fettouh H; Baumert H; Cathelineau X; Doublet JD; Fromont G; Vallancien G J Urol; 2003 Apr; 169(4):1261-6. PubMed ID: 12629339 [TBL] [Abstract][Full Text] [Related]